¡Desconecta con la aplicación Player FM !
Hema Now: Episode 8: What’s Next in Lymphoma Diagnosis and Treatment?
Manage episode 461128298 series 3412919
This week, Jonathan is joined by Marc Hoffman, Associate Professor in Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center, to discuss novel therapies for B-cell malignancies and current challenges in hemato-oncology.
Timestamps:
(00:00)-Introduction
(03:24)-What is molecular biophysics?
(07:01)-Marc’s journey into hemato-oncology
(09:36)-Advice to young doctors
(13:08)-Treatment advances in diffuse large B-cell lymphoma
(19:11)-BRUIN study: pirtobrutinib for B-cell malignancies
(26:15)-Challenges in CAR-T therapy implementation
(31:31)-A pharmaceutical perspective
(38:10)-Regulatory insights into clinical trials
(40:58)-New horizons in hemato-oncology
(44:26)-Marc’s three wishes for healthcare
200 episodios
Manage episode 461128298 series 3412919
This week, Jonathan is joined by Marc Hoffman, Associate Professor in Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center, to discuss novel therapies for B-cell malignancies and current challenges in hemato-oncology.
Timestamps:
(00:00)-Introduction
(03:24)-What is molecular biophysics?
(07:01)-Marc’s journey into hemato-oncology
(09:36)-Advice to young doctors
(13:08)-Treatment advances in diffuse large B-cell lymphoma
(19:11)-BRUIN study: pirtobrutinib for B-cell malignancies
(26:15)-Challenges in CAR-T therapy implementation
(31:31)-A pharmaceutical perspective
(38:10)-Regulatory insights into clinical trials
(40:58)-New horizons in hemato-oncology
(44:26)-Marc’s three wishes for healthcare
200 episodios
Todos los episodios
×Bienvenido a Player FM!
Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.